C-myc expression in cell lines derived from chronic myeloid leukemia.
Gómez-Casares
M Teresa
MT
Servicio de Hematología, Hospital Dr. Negrín, Las Palmas, Spain.
Vaqué
Jose P
JP
Lemes
Angelina
A
Molero
Teresa
T
Delgado
M Dolores
MD
León
Javier
J
D000970:Antineoplastic Agents / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects; D001549:Benzamides; D002066:Busulfan / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D045744:Cell Line, Tumor / Q000187:drug effects / Q000378:metabolism; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D016259:Genes, myc; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology; D000068877:Imatinib Mesylate; D016898:Interferon-alpha / Q000494:pharmacology; D020014:K562 Cells / Q000187:drug effects / Q000378:metabolism; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D009363:Neoplasm Proteins / Q000096:biosynthesis* / Q000235:genetics; D010879:Piperazines / Q000494:pharmacology; D016271:Proto-Oncogene Proteins c-myc / Q000096:biosynthesis*; D011743:Pyrimidines / Q000494:pharmacology
D000970:Antineoplastic Agents; D001549:Benzamides; D016898:Interferon-alpha; D009363:Neoplasm Proteins; D010879:Piperazines; D016271:Proto-Oncogene Proteins c-myc; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D002066:Busulfan; D006918:Hydroxyurea